Social Security Adds Pericardial Mesothelioma to Disabilities List

The U.S. Social Security Administration has added pericardial mesothelioma to its Compassionate Allowances list, accelerating the disabilities application process for this very rare cancer. Its decision was prompted by the work of Missy Miller, medical outreach director at The Mesothelioma Center. She made the request with the Social Security disability office almost a year ago on behalf of a patient. The Compassionate Allowances program is reserved for severe medical diseases and conditions that automatically meet Social Security standards for disability benefits. It cuts short the often drawn-out application process. Both pleural and peritoneal mesothelioma, more common forms of the cancer, have been part of the program for years, but pericardial mesothelioma was never included – until now. “This is huge, a really big deal for these patients,” Miller said. “I’m humbled, and very excited, by what we’ve done. I was assisting a single patient in this case, but we’ve now helped patients everywhere.” Highlighting Pericardial Mesothelioma Pericardial mesothelioma is a rare, asbestos-related cancer that originates in the pericardium, the protective membrane lining the heart. It accounts for just 1% of all mesothelioma cases in the U.S., which is estimated at 3,000 patients annually. Because clinical symptoms are usually nonspecific, the diagnosis often comes late in disease development when treatment is only pal...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news

Related Links:

This article is licensed under aCreative Commons Attribution-NonCommercial 3.0 Unported Licence.Bjoern C Froehlich, Robert Popp, Constance A Sobsey, Sahar Ibrahim, Andre M LeBlanc, Yassene Mohammed, Marguerite Buchanan, Adriana Aguilar-Mahecha, Oliver Poetz, Michael X Chen, Alan Spatz, Mark Basik, Gerald Batist, Rene Zahedi, Christoph H. Borchers The PI3-kinase/AKT/mTOR pathway plays a central role in cancer signaling. While p110 α is the catalytic α-subunit of PI3-kinase and a major drug target, PTEN is the main negative regulator of... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Analyst latest articles - Category: Chemistry Authors: Source Type: research
Thread Starter Should I apply fo these Unis for medicine? Follow 9 minutes ago 9m ago Quote: Originally Posted by tabsmason GCSE’s: 98887777776 (9,8 english 8 maths and 777 in chem bio phys) AS levels: AAAA (chemistry biology psychology maths) Predicted A-Leve...
Source: The Student Room - Category: Universities & Medical Training Authors: Tags: Medicine Source Type: forums
The pandemic has exposed flaws in services for people who can ’t easily access a drive-through window for Covid shots or testing or can’t read prescription labels.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Drugs (Pharmaceuticals) Drugstores Disabilities Labeling and Labels (Product) Blindness Coronavirus (2019-nCoV) Braille Containers and Packaging your-feed-science your-feed-healthcare audio-neutral-informative Source Type: news
ConclusionsThis systematic review suggests that women with HPV- and p16-positive vaginal cancer have an improved prognosis compared with those with HPV- or p16-negative vaginal cancer. Results for p53 were varied, and no conclusion could be reached. Only 12 studies could be included in the review, of which most were based on small populations. Hence, further and larger studies on the prognostic impact of HPV, p16, and p53 in vaginal cancer are warranted.
Source: Acta Obstetricia et Gynecologica Scandinavica - Category: OBGYN Authors: Tags: SYSTEMATIC REVIEW Source Type: research
This study aims to detail the characteristics of chemotherapy-related acute kidney injury (CR-AKI) and investigate its effect on patient outcomes.MethodsThis is a multicenter cross-sectional study of cancer patients with CR-AKI screened from hospital-acquired adult AKI patients based on a nationwide AKI survey in China.ResultsOf the 3468 patients with hospital-acquired AKI, 258 cases of CR-AKI were identified. Of the patients, 20.1% (52/258) were ≥ 70 years old. Among the 258 CR-AKI cases, 61 (23.6%) reached AKI stage 3, and 75 (29.1%) reached AKI stage 2. The remaining 122 (47.3%) remained at AKI stage 1. A total of 41...
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research
In CMML, neoplastic monocytes can be distinguished based on their immunophenotype. Supportive care myeloid growth factors in concomitant extranodal non-Hodgkin Lymphoma are safe. AbstractIn CMML, neoplastic monocytes can be distinguished based on their immunophenotype. Supportive care myeloid growth factors in concomitant extranodal non-Hodgkin Lymphoma are safe.
Source: Clinical Case Reports - Category: General Medicine Authors: Tags: CASE REPORT Source Type: research
ConclusionsChemotherapy with FOLFIRNOX or gemcitabine/nab-paclitaxel induces variable changes in circulating T-cell populations that may provide prognostic information in PDAC.
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research
AbstractMethylation of N6-adenosine (m6A) is the most prevalent internal RNA modification and is especially common among the messenger RNAs. These m6A modifications regulate splicing, translocation, stability and translation of RNA through dynamic and reversible interactions with m6A-binding proteins, namely the writers, erasers and readers. RNA methyltransferases catalyze the m6A modifications, while demethylases reverse this methylation. Deregulation of the m6A modification process has been implicated in human carcinogenesis, including melanoma —which carries one of the highest mutant rates. In this review, we prov...
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research
ConclusionPelvic floor dysfunction commonly deteriorates and negatively impacts on quality of life after minimally invasive radical hysterectomy, especially bowel function after TMMR. Pelvic floor symptoms should routinely be addressed pre- and postoperatively.
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research
AbstractCancer genomics has evolved over the years from understanding the pathogenesis of cancer to screening the future possibilities of cancer occurrence. Understanding the genetic profile of tumors holds a prognostic as well as a predictive value in this era of therapeutic surveillance, molecular remission, and precision medicine. Identifying molecular markers in tumors is the current standard of approach, and requires an efficient combination of an accessible sample type and a profoundly sensitive technique. Liquid biopsy or cell-free DNA has evolved as a novel sample type with promising results in recent years. Althou...
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research
More News: Asbestosis | Ataxia | Baylor College of Medicine | Cancer | Cancer & Oncology | Carcinoma | Cardiology | Disability | Environmental Health | Government | Health Insurance | Heart | Hodgkin's Disease | Insurance | Lymphoma | Mesothelioma | National Institutes of Health (NIH) | Palliative | Websites | Zika Virus